Target Gene/Pathway(薬物標的遺伝子/パスウェイリスト)

e.g. "Sirolimus", "アダリムマブ", "MAP2K"

ABCDEFGH I JKLMNOPQRSTUVWXYZother

33 / 286 pathways

No. KEGG PATHWAY   💬 Info on mouse-over
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES
💬 Info on mouse-over
KEGG DRUG
💬 Info on mouse-over
DrugBank 指定難病告示番号
💬 Info on mouse-over
1 Adipocytokine signaling pathway💬
1件: JAK2💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
2 AGE-RAGE signaling pathway in diabetic complications💬
1件: JAK2💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
3 Chemokine signaling pathway💬
1件: JAK2💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
4 Cholinergic synapse💬
1件: JAK2💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
5 Coronavirus disease - COVID-19💬
1件: JAK1💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
6 EGFR tyrosine kinase inhibitor resistance💬
2件: JAK1, JAK2💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
7 Epstein-Barr virus infection💬
1件: JAK1💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
8 Growth hormone synthesis, secretion and action💬
1件: JAK2💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
9 Hepatitis B💬
2件: JAK1, JAK2💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
10 Hepatitis C💬
1件: JAK1💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
11 Herpes simplex virus 1 infection💬
2件: JAK1, JAK2💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
12 Human cytomegalovirus infection💬
1件: JAK1💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
13 Human papillomavirus infection💬
1件: JAK1💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
14 Human T-cell leukemia virus 1 infection💬
1件: JAK1💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
15 Influenza A💬
2件: JAK1, JAK2💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
16 JAK-STAT signaling pathway💬
2件: JAK1, JAK2💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
17 Kaposi sarcoma-associated herpesvirus infection💬
2件: JAK1, JAK2💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
18 Leishmaniasis💬
2件: JAK1, JAK2💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
19 Measles💬
1件: JAK1💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
20 Necroptosis💬
2件: JAK1, JAK2💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
21 NOD-like receptor signaling pathway💬
1件: JAK1💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
22 Osteoclast differentiation💬
1件: JAK1💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
23 Pancreatic cancer💬
1件: JAK1💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
24 Pathways in cancer💬
2件: JAK1, JAK2💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
25 PD-L1 expression and PD-1 checkpoint pathway in cancer💬
2件: JAK1, JAK2💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
26 PI3K-Akt signaling pathway💬
2件: JAK1, JAK2💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
27 Prolactin signaling pathway💬
1件: JAK2💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
28 Signaling pathways regulating pluripotency of stem cells💬
2件: JAK1, JAK2💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
29 Th1 and Th2 cell differentiation💬
2件: JAK1, JAK2💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
30 Th17 cell differentiation💬
2件: JAK1, JAK2💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
31 Toxoplasmosis💬
2件: JAK1, JAK2💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
32 Tuberculosis💬
2件: JAK1, JAK2💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬
33 Viral carcinogenesis💬
1件: JAK1💬 D10308💬 Baricitinib 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325💬